Table 5.

Unadjusted proportional incidence ratios (PIR) of non-metro vs metro population with HIV/AIDS by patient and tumor characteristics, Iowa, 1991–2015.

		HIV/AIDS Population
		Non-metro	Metro	PIR	95% CI
		(N=144)	(N=340)
Cancer diagnosis	1991–1998	44	114	0.91	(0.71, 1.17)
year	1999–2006	37	77	1.13	(0.86, 1.50)
	2007–2015	63	149	1.00	(0.83, 1.20)
Cancer diagnosis	00–29	11	28	0.93	(0.53, 1.64)
age (years)	30–39	27	88	0.72	(0.52, 1.02)
	40–49	48	113	1.00	(0.80, 1.26)
	50–59	42	70	1.42	(1.10, 1.83)
	60+	16	41	0.92	(0.58, 1.46)
Race	White	132	280	1.11	(1.06, 1.17)
	Other	12	60	0.47	(0.27, 0.81)
Sex	Female	16	41	0.92	(0.58, 1.46)
	Male	128	299	1.01	(0.95, 1.07)
Site / Histology	Anus and Anal Canal / Squamous Cell Neoplasms	14	29	1.14	(0.69, 1.88)
	Female Genital Organs / Squamous Cell Neoplasms	6	7	2.02	(0.92, 4.43)
	Kaposi Sarcoma	20	69	0.68	(0.46, 1.03)
	Lung and Bronchus / Adenocarcinomas	7	12	1.38	(0.67, 2.84)
	Lung and Bronchus / Other	5	14	0.84	(0.36, 2.00)
	Lymph Nodes / NHL, DLBCL	19	56	0.80	(0.53, 1.22)
	Lymph Nodes / NHL, Other	20	46	1.03	(0.68, 1.54)
	Lymph Nodes / Other	8	15	1.26	(0.64, 2.47)
	Other Sites / Adenocarcinomas	13	34	0.90	(0.54, 1.52)
	Other Sites / Squamous Cell Neoplasms	11	14	1.86	(1.05, 3.27)
	Other Sites / Other	21	44	1.13	(0.76, 1.67)

^*Significantly elevated PIRs are bolded

Abbreviations: DLBCL: diffuse large B-cell lymphoma